Efficacy and safety of using Etelcalcetide for controlling secondary hyperparathyroidism

Efficacy and safety of using Etelcalcetide for controlling secondary hyperparathyroidism

<h3>Background</h3><p dir="ltr">In Qatar, secondary hyperparathyroidism (SHPT) is a common problem in haemodialysis (HD) patients, associated with significant clinical consequences for Chronic Kidney Disease (CKD) patients, including osteitis fibrosa cystica and calcific...

Full description

Saved in:
Bibliographic Details
Main Author: Tarek Fouda (18472476) (author)
Other Authors: Anees Jamil (18505330) (author), Alaa Ibrahim (7401809) (author), Sahar Aly (6374201) (author), Samah Saeed (18505333) (author), Abeer Ahmed (448250) (author), Thresiamma Abraham (18505335) (author), Asha Jhadav (18505338) (author), Leila Mougou (18505341) (author), Montasser Eloueti (18505343) (author), Nahid Ibrahim (18505344) (author), Rania A/Aziz (18472470) (author), Reema Patrao (18505345) (author), Teha Al Mohannadi (18505348) (author), Wafa Ali (18505349) (author), Karima Ahmed (18505351) (author), Shaza Yousif (18505354) (author), Fadwa Al Ali (18505356) (author), Tarek Ghonimi (16986138) (author), Mohamed Al Kadi (18505359) (author), Abdulah Hamad (18505361) (author), Hassan Al Malki (18505362) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Pharmacology and pharmaceutical sciences
Health sciences
Health services and systems
Dialysis
Calcimimetic agent
Hyperparathyroidism
Etelcalcetide
Phosphate binders
Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items